查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
人类原代细胞市场：按产品类型、按分离、按细胞类型、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、预测 2023-2030
市场调查报告书
商品编码
1299773

人类原代细胞市场：按产品类型、按分离、按细胞类型、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、预测 2023-2030

Human Primary Cells Market with COVID-19 Impact Analysis, By Product Type, By Separation, By Cell Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 323 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年人类原代细胞市场规模将达到 13.607 亿美元，2023 年至 2030 年復合年增长率为 11.5%

人类原代细胞市场 - 市场动态：

在原代细胞市场增长的背景下，有老年人口的增加、研发的进步、慢性病患者的增加。 此外，医药市场在先进测试和药物开发方面正在显着增长。 因此，人类原代细胞市场的采用预计将会增加。 然而，原材料供应有限和昂贵的工艺是预测期内阻碍市场增长的主要因素。

此外，原代细胞培养物还可用于鑑定新药的细胞毒性。 此外，原代人类细胞被用作动物模型的替代品来测试化学品、化妆品和新药的效果。 这些是预计推动市场增长的主要因素。 COVID-19 大流行对人类原代细胞市场产生了积极影响。 研究人员利用人类原代细胞来了解传染病。 特征化和标准化的上皮细胞培养模型正在帮助我们了解冠状病毒破坏的物理屏障。 该模型将有助于模拟呼吸系统的特性和功能，为将研究成果转化为医学应用提供突破。

人类原代细胞市场 - 细分分析：

全球人类原代细胞市场根据产品类型、分离、细胞类型、应用和地区进行细分。

按照产品类型，市场分为三个部分：人类原代细胞、试剂和补充剂以及培养基。 试剂和补充剂领域预计将主导市场。 人类原代细胞参与试剂和补充剂製造和研究的常规应用。 由于人类原代细胞生长脆弱，试剂和补充剂被认为非常重要。

根据分离，市场分为提取、□法分离、机械分离等。 在预测期内，□降解可能会保持其主导地位。 与其他分离原代人类细胞的技术相比，□消化因其速度相对较快、代表性样品产量高以及对培养物损伤较小等优点而受到重视。原因之一是

市场按细胞类型分为动物和人类。 预计动物细分市场将占据最大的市场份额。 越来越多地使用动物源性人类原代细胞来开发疫苗是推动该领域发展的关键因素。

市场按应用细分为组织培养/组织工程、疫苗製造、基因治疗/再生医学、毒性测试/药物筛选、病毒学、癌症研究、干细胞治疗、模型系统、产前诊断和其他 9 个类别. 分类为 预计疫苗生产领域将在预测期内主导市场。 动物原代培养物越来越多地用于生产用于生产各种疫苗的病毒，包括乙型肝炎和麻疹疫苗。

人类原代细胞市场 - 竞争格局：

由于对研发活动的大力投资，通过使用人类原代细胞来治疗各种免疫缺陷疾病来开发更好的治疗方法，人类原代细胞市场在全球范围内迅速增长。 此外，随着生物製药和生物技术领域的发展，医学研究人员不断探索利用来自人类和动物组织的原代细胞来治疗恶性癌症。 此外，主要参与者正在采取新产品发布、併购、研发支出、合作伙伴关係和联盟等策略来增加市场收入。 例如，2021 年 8 月，Axol Bioscience Ltd 宣布与 CENSO Biotechnologies 合併。 合併后的实体将成为服务解决方案和产品的领先提供商。 此外，它将为客户提供一整套服务，包括经过验证的、即用型细胞系、强大的功能数据、定制能力和广泛的专业知识，并且交货时间更短。

研究的主要特点

这份关于人类原代细胞市场的研究报告提供了以2022年为基准年的市场规模、复合年增长率（CAGR%）、估计和预测（2023-2030年）。

本研究报告阐明了不同细分市场/国家的潜在增长机会，并描述了人类原代细胞市场有吸引力的投资主张矩阵。

总体报告确定了新的投资机会、现有企业面临的挑战以及人类原代细胞市场可持续发展的增长动力。

研究范围详细讨论了 COVID-19 对人类原代细胞市场规模、预测、复合年增长率和市场动态的影响。 它还涵盖了对新冠疫情后人类原代细胞市场的详细见解。

为了向本报告的用户提供对人类原代细胞市场的全面了解，我们还对人类原代细胞市场进行了竞争格局和关键创新者分析。

本报告涵盖了增长前景映射分析，根据市场规模、增长率和吸引力对所有行业领域进行基准测试。

该报告提供了主要市场参与者的详细公司概况，以帮助您了解在人类原代细胞市场运营的公司的财务信息和战略举措。

报告还揭示了市场主要进入者不仅在全球层面而且在区域层面的重大收购和兼併、联盟和合资企业、新产品推出、研发和区域扩张。Masu。

全球人类原代细胞市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师。

内容

第一章人类原代细胞市场概述

  • 调查范围

第 2 章执行摘要

  • 市场细分
  • 竞争考虑因素

第三章人类原代细胞主要市场趋势

  • 人类原代细胞市场驱动因素
  • 人原代细胞市场製约因素
  • 人类原代细胞的市场机会
  • 人类原代细胞市场的未来趋势

第四章人体原代细胞产业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 监管框架分析

第五章人类原代细胞市场：COVID-19 的影响分析

  • 新冠肺炎 (COVID-19) 疫情爆发前的影响分析
  • 新冠肺炎 (COVID-19) 疫情后的影响分析

第六章人类原代细胞市场情况

  • 2022 年人类原代细胞市场份额分析
  • 主要製造商的详细数据
    • 已成立公司分析
    • 初创企业分析

第 7 章人类原代细胞市场 - 按产品类型

  • 概述
    • 按产品类型分析细分市场份额
    • 人类原代细胞
    • 试剂和补充剂
    • 媒体

第 8 章人类原代细胞市场 - 通过隔离

  • 概述
    • 按细分市场划分的细分市场份额分析
    • 外植体法
    • □降解
    • 机械分离
    • 其他

第 9 章主要人类细胞市场 - 按细胞类型

  • 概述
    • 按细胞类型划分的细分市场份额分析
    • 动物
    • 人类

第 10 章主要人类细胞市场 - 按应用

  • 概述
    • 按应用划分的细分市场份额分析
    • 组织培养和组织工程
    • 疫苗生产
    • 基因治疗和再生医学
    • 毒性测试和药物筛选
    • 癌症研究
    • 干细胞疗法
    • 模型系统
    • 产前诊断
    • 其他

第 11 章主要人类细胞市场 - 按地区

  • 简介
  • 北美
    • 概述
    • 北美原代人体细胞的主要製造商
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲原代人体细胞的主要製造商
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区主要人类原代细胞製造商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲领先的主要人体细胞製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概述
    • 中东和非洲人类原代细胞的主要製造商
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第 12 章主要供应商分析 - 人类原代细胞行业

  • 竞赛仪表板
  • 公司简介
    • Merck Group
    • ATCC
    • Thermo Fisher Scientific Inc
    • Sigma-Aldrich Co.
    • Charles River Laboratories
    • Merck Group
    • Axol Bioscience
    • ReachBio Research Labs
    • STEMCELL Technologies Inc
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell-Human Centered Science
    • ZenBio, Inc.
    • AllCells

第十三章分析师的全面观点

Product Code: ANV1363

REPORT HIGHLIGHT

Human Primary Cells market size was valued at USD 1,360.7 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.

Human Primary Cells are also known as mature cells extracted from living tissues of humans and animals after that processed to establish them for utilization in appropriate cell therapies. Additionally, Human Primary Cells are also used in several applications such as cancer research, 3D cell culture, tissue replacement, stem cell therapy, and virology. 3D cell culture is increasingly used by researchers to study cell biology and biochemistry, cell-pathogen interactions, drug effects, and cell signaling.

Human Primary Cells Market- Market Dynamics:

The primary cell market growth is attributed to the increasing geriatric population, advancements in development and research, and a rise in cases of chronic diseases. Additionally pharmaceutical market is growing significantly in advanced testing and drug development. This in turn projected to facilitate increased adoption of the Human Primary Cells market. However, restrictions implemented for the utilization of raw materials and expensive processes are the major factors hindering the market growth during the forecast period.

Moreover, primary cell cultures are used to identify the cytotoxicity of new drugs. Furthermore, Human Primary Cells are used in the place of animal models to test the effects of chemicals, cosmetics, and new drugs. These are some major factors expected to drive market growth. The COVID-19 pandemic has impacted the Human Primary Cells market positively. Human Primary Cells are used by researchers for understanding the infection. Characterized and standardized epithelium cell culture models are helping to understand the physical barrier devastated by the coronavirus. The models can assist mimic the properties and functions of the respiratory tract which leads to a breakthrough for a research outcome moving into a medical application

Human Primary Cells Market- Segmentation Analysis:

The global Human Primary Cells market is segmented on the basis of product type, separation, cell type, application, and region.

The market is divided into three categories based on product type: Human Primary Cells, reagents and supplements, and media. The reagents and supplements sector is expected to possess the market. Human Primary Cells are involved in reagents and supplements' routine application in manufacturing and research. The reagents and supplements are considered very crucial as Human Primary Cells are fragile for their growth.

The market is divided into three categories based on separation: explant method, enzymatic degradation, mechanical separation, and others. The enzymatic degradation sector is likely to maintain its dominance during the forecast period. This is partly due to its high preference at the place of other techniques for the separation of Human Primary Cells owing to its advantages such as comparatively fast, high yield of a representative sample, and less damage to cultures.

The market is divided into two categories based on cell type: animal and human. The animal sector is expected to hold the largest market share. For vaccine development, increasing the application of animal-origin Human Primary Cells are essential factor propelling the segment growth.

The market is divided into nine categories based on application: tissue culture & tissue engineering, vaccine production, gene therapy and regenerative medicine, toxicity testing & drug screening, virology, cancer research, stem cell therapy, model system, prenatal diagnosis, and others. The vaccine production sector is expected to dominate the market over the forecast period. Rising use of primary animal culture for the production of virus that is later utilized for producing various vaccines including hepatitis B and measles.

Human Primary Cells Market-Competitive Landscape:

The Human Primary Cells market is rapidly driven globally by robust investment in research and development activities for the increment of better therapies where Human Primary Cells can be utilized to treat various immunodeficiency disorders. Additionally, with The growth in biopharmaceutical and biotechnology sectors, medical researchers are continuously working on using Human Primary Cells from human and animal tissues for the treatment of malignant cancers. Moreover, key players are adopting strategies such as new product launches, mergers & acquisitions, R&D spending, partnerships, and collaboration to enhance their market revenue. For instance, in August 2021, Axol Bioscience Ltd announced its merger with CENSO Biotechnologies. The merged entity will become a leading provider of service solutions and products. Additionally, it will provide customers with validated ready-to-use cell lines and a suite of services with robust functional data, customization capabilities, and broader expertise, all with shorter lead times.

Key features of the study:

This proposed research study on Human Primary Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Human Primary Cells market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Human Primary Cells market.

Impact of COVID-19 on Human Primary Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Human Primary Cells market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Human Primary Cells market, we have also included competitive landscape and key innovator analysis for Human Primary Cells market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the Human Primary Cells market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global Human Primary Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN PRIMARY CELLS MARKET KEY PLAYERS

  • Merck Group
  • ATCC
  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich Co.
  • Charles River Laboratories
  • Merck Group
  • Axol Bioscience
  • ReachBio Research Labs
  • STEMCELL Technologies Inc
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell - Human Centered Science
  • ZenBio, Inc.
  • AllCells

GLOBAL HUMAN PRIMARY CELLS MARKET, BY PRODUCT TYPE

  • Human Primary Cells
  • Reagents and Supplements
  • Media

GLOBAL HUMAN PRIMARY CELLS MARKET, BY SEPARATION

  • Explant Method
  • Enzymatic Degradation
  • Mechanical Separation
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY CELL TYPE

  • Animal
  • Human

GLOBAL HUMAN PRIMARY CELLS MARKET, BY APPLICATION

  • Tissue Culture & Tissue Engineering
  • Vaccine Production
  • Gene Therapy and Regenerative Medicine
  • Toxicity Testing and Drug Screening
  • Cancer Research
  • Stem Cell Therapy
  • Model System
  • Prenatal Diagnosis
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Primary Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Primary Cells Market Snippet by Product Type
    • 2.1.2. Human Primary Cells Market Snippet by Separation
    • 2.1.3. Human Primary Cells Market Snippet by Cell Type
    • 2.1.4. Human Primary Cells Market Snippet by Application
    • 2.1.5. Human Primary Cells Market Snippet by Country
    • 2.1.6. Human Primary Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Primary Cells Key Market Trends

  • 3.1. Human Primary Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Primary Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Primary Cells Market Opportunities
  • 3.4. Human Primary Cells Market Future Trends

4. Human Primary Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Primary Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Primary Cells Market Landscape

  • 6.1. Human Primary Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Primary Cells Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Human Primary Cells
    • 7.1.3. Reagents and Supplements
    • 7.1.4. Media

8. Human Primary Cells Market - By Separation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Separation, 2022&2030 (%)
    • 8.1.2. Explant Method
    • 8.1.3. Enzymatic Degradation
    • 8.1.4. Mechanical Separation
    • 8.1.5. Others

9. Human Primary Cells Market - By Cell Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cell Type, 2022&2030 (%)
    • 9.1.2. Animal
    • 9.1.3. Human

10. Human Primary Cells Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 10.1.2. Tissue Culture & Tissue Engineering
    • 10.1.3. Vaccine Production
    • 10.1.4. Gene Therapy and Regenerative Medicine
    • 10.1.5. Toxicity Testing and Drug Screening
    • 10.1.6. Cancer Research
    • 10.1.7. Stem Cell Therapy
    • 10.1.8. Model System
    • 10.1.9. Prenatal Diagnosis
    • 10.1.10. Others

11. Human Primary Cells Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Human Primary Cells Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Human Primary Cells Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Human Primary Cells Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Human Primary Cells Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Human Primary Cells Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Human Primary Cells Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Merck Group
    • 12.2.2. ATCC
    • 12.2.3. Thermo Fisher Scientific Inc
    • 12.2.4. Sigma-Aldrich Co.
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Merck Group
    • 12.2.7. Axol Bioscience
    • 12.2.8. ReachBio Research Labs
    • 12.2.9. STEMCELL Technologies Inc
    • 12.2.10. Lonza
    • 12.2.11. Cell Biologics, Inc.
    • 12.2.12. PromoCell - Human Centered Science
    • 12.2.13. ZenBio, Inc.
    • 12.2.14. AllCells

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Primary Cells Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Human Primary Cells Market, by Product Type2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: SeparationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Separation
  • TABLE Global Human Primary Cells Market, by Separation2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: Regional snapshot (2022)
  • TABLE Human Primary Cells Market: Cell Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Human Primary Cells Market, by Cell Type 2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Human Primary Cells Market, by Application2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Primary Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE EuropeHuman Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Application, 2018-2030 (USD Million)